MyAverix Finance
F · Healthcare
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO)
Drug Manufacturers - Specialty & Generic
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $44.80B, P/E ratio is 45.00, net margin is 24.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0BO
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) — FAQ
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market cap?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) has a reported market cap of $44.80B (data as of 2026-05-24).
What is 0BO's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) is 45.00 (data as of 2026-05-24).
Does Jiangsu Hengrui Pharmaceuticals Co.,Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Hengrui Pharmaceuticals Co.,Ltd in?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 0BO listed on?
0BO is listed on F.
What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's net margin?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) reports a net margin of 24.9% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.